JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis

BACKGROUND: Systemic sclerosis (SSc) is a rare disabling connective tissue disease with few available treatment options. Diffuse cutaneous systemic sclerosis (dcSSc) is associated with high mortality. A previous experiment has shown that JAK2 inhibitor can significantly improve skin fibrosis in bleo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Zhanying, Su, Xuehan, Han, Guangming, Xue, Ruzeng, Chen, Yangxia, Chen, Ye, Wang, Huan, Yang, Bin, Liang, Yunsheng, Ji, Suyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208297/
https://www.ncbi.nlm.nih.gov/pubmed/35733864
http://dx.doi.org/10.3389/fmed.2022.859330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208297/
https://www.ncbi.nlm.nih.gov/pubmed/35733864
http://dx.doi.org/10.3389/fmed.2022.859330

Ejemplares similares